Thursday, October 7, 2021

Is salesforce.com inc. (NYSE:CRM) Worth A Patient Look At Current Prices?

(NYSE:CRM)’s traded shares stood at 4.47 million during the last session, with the company’s beta value hitting 1.04. At the close of trading, the stock’s price was $275.27, to imply an increase of 1.

from crm - BingNews https://ift.tt/3oHWj55
October 07, 2021 at 12:15PM

No comments:

Post a Comment